Explore
Validate
LearnHPA020134
antibody from Atlas Antibodies
Targeting: URGCP
DKFZp666G166, DKFZp686O0457, FLJ20654, KIAA1507, URG4
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA020134 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA020134, RRID:AB_1858652
- Product name
- Anti-URGCP
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human URGCP, Gene description: upregulator of cell proliferation, Alternative Gene Names: DKFZp666G166, DKFZp686O0457, FLJ20654, KIAA1507, URG4, Validated applications: IHC, Uniprot ID: Q8TCY9, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.6 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references URG4 expression is a novel prognostic factor for the progression of nasopharyngeal carcinoma and overall survival of patient
URG4 overexpression is correlated with cervical cancer progression and poor prognosis in patients with early-stage cervical cancer
Yu G, Meng Q, Zeng C, He B, Zhang S, Zhang T
OncoTargets and Therapy 2016
OncoTargets and Therapy 2016
URG4 overexpression is correlated with cervical cancer progression and poor prognosis in patients with early-stage cervical cancer
Zhang L, Huang H, Zhang L, Hou T, Wu S, Huang Q, Song L, Liu J
BMC Cancer 2014;14(1)
BMC Cancer 2014;14(1)
No comments: Submit comment
No validations: Submit validation data